OSR Health, Inc. Common Stock (OSRH) Stock Price

OSRHStock
$0.22−59.64%52W
Market Cap$7.73M
P/E—
PEG Ratio—
Div yield—
Beta0.53

OSRH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-66.61%
Price vs S&P 500 (4W)-6.88%
VGM Score29.70

OSRH Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q4 2025-$0.10-$0.16-60.00%(-$0.06)

OSRH Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.14
4.14
4.14
4.14

Industry Peers — Surgical & Medical Instruments(142)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
OSRHOSR Health, Inc. Common Stock
CFD4.4x—35.3%-933.7%$0.22
SYKStryker CorporationCBC4.4x11.8%65.3%21.3%$294.66
MMM3M CompanyCDB3.4x-5.0%39.4%18.4%$164.75
BSXBoston Scientific Corp.CBC3.1x15.2%69.5%19.8%$44.39
BDXBecton, Dickinson and Co.BDA2.5x6.3%46.7%9.6%$191.75
MDLNMedline Inc. Class A common stockCDC1.6x—26.2%6.0%$35.96
RMDResMed Inc.CCB5.9x12.1%61.1%33.4%$238.97
DXCMDexCom, Inc.CBB6.5x19.3%64.3%22.9%$86.04
WSTWest Pharmaceutical Services, Inc.DCA8.5x7.4%36.8%20.4%$384.02
SOLVSolventum CorporationCCB1.8x—54.8%23.9%$85.81
BAXBaxter International Inc.BDB1.1x-0.8%30.7%-2.3%$25.28

About OSR Health, Inc. Common Stock

OSR Holdings Inc operates in three healthcare segments: oral immunotherapy development for cancer, design-augmented biologics for age-related and degenerative diseases, and neurovascular medical device distribution in Korea. The company develops and commercializes therapeutic and medical device solutions to improve patient outcomes.